 |
PDBsum entry 6ezh
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Novel multitarget-Directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of alzheimer'S disease: synthesis, Evaluation, And structural characterization of their complexes with acetylcholinesterase.
|
 |
|
Authors
|
 |
J.Lalut,
G.Santoni,
D.Karila,
C.Lecoutey,
A.Davis,
F.Nachon,
I.Silman,
J.Sussman,
M.Weik,
T.Maurice,
P.Dallemagne,
C.Rochais.
|
 |
|
Ref.
|
 |
Eur J Med Chem, 2018,
162,
234-248.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Pleiotropic intervention may be a requirement for effective limitation of the
progression of multifactorial diseases such as Alzheimer's Disease. One approach
to such intervention is to design a single chemical entity capable of acting on
two or more targets of interest, which are accordingly known as Multi-Target
Directed Ligands (MTDLs). We recently described donecopride, the first MTDL able
to simultaneously inhibit acetylcholinesterase and act as an agonist of the
5-HT4 receptor, which displays promising activities in vivo.
Pharmacomodulation of donecopride allowed us to develop a novel series of indole
derivatives possessing interesting in vitro activities toward AChE and the
σ1 receptor. The crystal structures of complexes of the most
promising compounds with Torpedo californica AChE were solved in order to
further understand their mode of inhibition.
|
 |
|
|
|
|
 |